The STARS (Stuttering Treatment & Research Society) held its successful inaugural Research & Education Conference on September 13, 2025, in Laguna Niguel, California, bringing together medical professionals to explore the latest in stuttering research and treatment. Highlights included expert panels on neurobiology, diagnostics, and therapies, as well as a keynote by athlete Bo Jackson, who […]
Dr. Gerald Maguire, President and Founder of the Stuttering Research and Treatment Society (STARS), along with STARS Advisory Committee Member Zach Greene, represented the organization at the 39th Annual Psych Congress. The event brought together more than 3,000 physicians and nurse practitioners from across the country.
Dr. Gerald Maguire, an internationally recognized psychiatrist, researcher, and person who stutters, recently joined the Newfoundland and Labrador Stuttering Association to share his expertise on the neurobiology and treatment of stuttering. In his talk, Dr. Maguire explored the history and persistence of stuttering, the unique challenges faced by those who stutter, and the need for […]
From a neurology perspective, stuttering is a complex speech fluency disorder arising from brain network disruptions responsible for timing, motor control, and language processing. There is evidence that stuttering involves abnormalities in dopaminergic signaling, which may explain why some dopamine-modulating medications show benefit in subsets of patients.
Yoshikazu Kikuchi, MD, PhD, one of the international experts presenting at the STARS Conference, shared highlights from his research and experience in supporting individuals who stutter. Kikuchi shared his insights with Psychiatric Times in an exclusive interview.
“I’ve been on pharmacologic treatment for the past 3 years, and it’s totally changed the way that I’ve been able to communicate,” Samuel B. told Psychiatric Times during an exclusive interview at the STARS (Stuttering Treatment and Research Society) Research and Education Conference in Dana Point, California.